Eagle Pharmaceuticals Inc (EGRX)

Eagle Pharmaceuticals (EGRX) Stock Price & Analysis


EGRX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$18.02 - $47.71
Previous Close$18.3
Average Volume (3M)167.90K
Market Cap
Enterprise Value$302.77M
Total Cash (Recent Filing)$21.90M
Total Debt (Recent Filing)$76.33M
Price to Earnings (P/E)-83.8
Aug 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding13,091,344
10 Day Avg. Volume156,130
30 Day Avg. Volume167,897
Standard Deviation0.11
Financial Highlights & Ratios
Price to Book (P/B)4.10
Price to Sales (P/S)5.18
Price to Cash Flow (P/CF)1.90
P/FCF Ratio1.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.23
Enterprise Value/Gross Profit1.31
Enterprise Value/Ebitda8.24
Price Target Upside56.50% Upside
Rating ConsensusHold
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Eagle Pharmaceuticals Inc’s price range in the past 12 months?
Eagle Pharmaceuticals Inc lowest stock price was $18.02 and its highest was $47.71 in the past 12 months.
    What is Eagle Pharmaceuticals Inc’s market cap?
    Currently, no data Available
    When is Eagle Pharmaceuticals Inc’s upcoming earnings report date?
    Eagle Pharmaceuticals Inc’s upcoming earnings report date is Aug 08, 2023 which is in 61 days.
      How were Eagle Pharmaceuticals Inc’s earnings last quarter?
      Eagle Pharmaceuticals Inc released its earnings results on May 09, 2023. The company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.21.
        Is Eagle Pharmaceuticals Inc overvalued?
        According to Wall Street analysts Eagle Pharmaceuticals Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Eagle Pharmaceuticals Inc pay dividends?
          Eagle Pharmaceuticals Inc does not currently pay dividends.
          What is Eagle Pharmaceuticals Inc’s EPS estimate?
          Eagle Pharmaceuticals Inc’s EPS estimate is $0.99.
            How many shares outstanding does Eagle Pharmaceuticals Inc have?
            Eagle Pharmaceuticals Inc has 13,091,344 shares outstanding.
              What happened to Eagle Pharmaceuticals Inc’s price movement after its last earnings report?
              Eagle Pharmaceuticals Inc reported an EPS of $1.26 in its last earnings report, beating expectations of $1.05. Following the earnings report the stock price went down -13.301%.
                Which hedge fund is a major shareholder of Eagle Pharmaceuticals Inc?
                Among the largest hedge funds holding Eagle Pharmaceuticals Inc’s share is Brandes Investment Partners LP. It holds Eagle Pharmaceuticals Inc’s shares valued at 15M.


                  Eagle Pharmaceuticals Stock Smart Score

                  The Eagle Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Eagle Pharmaceuticals Inc

                  Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban, ryanodex, docetaxel injection, non-alcohol formulation and bendeka. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.


                  Top 5 ETFs holding EGRX

                  Market Value
                  Smart Score
                  Vanguard Health Care ETF
                  Fidelity MSCI Health Care Index ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  SPDR Portfolio S&P 1500 Composite Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold EGRX. The ETFs are listed according to market value of EGRX within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Pacira Pharmaceuticals
                  Spectrum Pharmaceuticals
                  Karyopharm Therapeutics
                  SAGE Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis